The therapies combine three proven medicines-Glycopyrronium, Formoterol, and Budesonide-to reduce airway obstruction, control ...

The company has launched Nebzmart® GFB Smartules® and Glenmark Airz® FB Smartules®, world's first nebulised, fixed-dose ...

Glenmark Pharma launches Nebzmart GFB & Airz FB Smartules, a fixed-dose triple therapy for COPD. Improves lung function & ...

Glenmark Pharmaceuticals announced the launch of Nebzmart GFB Smartules and Glenmark Airz FB Smartules, the world's first nebulized, fixed-dose triple therapy for the treatment of Chronic Obstructive ...

Glenmark Pharmaceuticals on Tuesday said it has launched the world's first nebulised, fixed-dose triple therapy ...

Sen. Raphael Warnock on Sunday intensified his calls for Health and Human Services Secretary Robert F. Kennedy Jr. to be ...

"Renalys eyes Japanese Filspari approval on Phase III IgA nephropathy win" was originally created and published by Clinical ...

In simulated operations described in Nature on 26 November 1, the slipknot technique allowed inexperienced surgeons to ...

Anti-APRIL antibody Voyxact (sibeprenlimab) has been approved by the US regulator to reduce proteinuria in adults with ...

Mechanical ventilation highlights the fundamental paradox of critical care: it can be both life-saving and life-threatening.

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...